Biochemical studies showed that patients with BCD have abnormal lipid metabolism, and the biochemical analysis of CYP4V2 showed that it is a fatty acid omega hydroxylase [6, 7]. The gene discussed is CYP4V2; the disease is Bietti crystalline dystrophy.